Mativ Holdings, Inc. (MATV) attracts very little sell-side coverage, so no robust published "consensus" exists. The most clearly identifiable current target is Sidoti & Company's $21, set by analyst Daniel Harriman and maintained through 2026; it is derived from a 17x multiple applied to a 2027 adjusted EPS (earnings per share) estimate of $1.25. Aggregator data points cluster in the same neighborhood: one feed lists a one-year average target near $21.42 within a narrow band of roughly $21 to $22, while another two-analyst sample spans a low near $19 and a high near $30. Because most credible, current figures sit tightly around $21, the rounded central target used throughout this article is $21, which should be read as the mean of a small, limited sample rather than a broad Street consensus.
Reasoning behind the targets emphasizes the same theme: margin expansion, improving cash generation, and balance-sheet repair outweighing subdued top-line growth. There are no recent headline upgrades or downgrades of note; the meaningful signal is the upward revision of Sidoti's target from $19 to $21 in November 2025 following record EBITDA (earnings before interest, taxes, depreciation, and amortization) margins.
With MATV closing at $11.41 on October 19, 2026, reaching $21 requires a gain of about 84%—a very large move by any standard. The stock sits above its 200-day moving average but below its 50-day average, reflecting a stock that has rallied hard off its 52-week low of $7.07 but has since pulled back from its 52-week high of $15.48. At a trailing P/E (price-to-earnings ratio) near 7 and a market capitalization around $630 million, MATV trades at a deeply discounted multiple, suggesting the market is pricing in continued demand uncertainty and elevated leverage rather than the earnings recovery embedded in the analyst target.
Mativ has delivered its strongest operating results since its 2022 merger, with record post-merger EBITDA margins, a sixth consecutive quarter of organic growth in the SAS segment, and a meaningful turnaround in FAM. Full-year 2025 free cash flow of roughly $94 million more than doubled the prior year and was the highest since the merger, enabling about $61 million of net-debt reduction. Management is targeting long-term net leverage of 2.5x to 3.5x, down from about 4.2x, and has refocused the portfolio away from legacy paper and tobacco-adjacent products toward filtration, tapes, liners, and healthcare films. If margins hold and deleveraging continues, the valuation re-rating implied by a $21 target becomes more plausible.
The principal obstacles are structural rather than trivial. Net debt remains high, with a debt-to-equity ratio above 200% and modest interest coverage, so the company has limited room for missteps in a downturn. Demand in several SAS end markets—labels, automotive tapes, and release liners—has been soft, particularly in Europe, and management has described a weak demand environment entering 2026. Revenue growth is projected at only a low-single-digit annual rate, well below the broader specialty chemicals industry. Finally, with such thin analyst coverage, the $21 target rests on few independent estimates and a 2027 earnings base that has yet to be delivered.
On the chart, MATV's 52-week range of $7.07 to $15.48 frames the current setup. The stock holds above its 200-day moving average near $10.30, a constructive sign, but trades below its 50-day average near $12.10, indicating short-term resistance overhead. Immediate supply appears in the $12–$12.20 zone, with the $15.48 prior high acting as the next major hurdle before any path toward $21. Support is visible near $11 and again near the 200-day average.
Analyst price targets typically reflect a roughly 12-month research horizon, and Sidoti's $21 target is anchored to 2027 earnings, implying a longer runway. Investors should watch the next earnings release (scheduled for early November 2026) for margin trends, free cash flow, and any net-debt progress, along with management's commentary on European demand and the Advanced Films turnaround. Debt-reduction milestones toward the 2.5x–3.5x leverage band and any change to the dividend or buyback program are also central to the thesis.
Traders tracking volatile, low-coverage names like MATV can supplement fundamental research with Tickeron's AI Daily Buy/Sell Signals. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. This can help traders discover new opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening alone. Explore the AI Daily Buy/Sell Signals to see how it can support your own process.
Can MATV reach $21? The target—drawn from a thin analyst sample anchored by Sidoti's $21—implies an 84% gain from the current $11.41 price, a very large move that would require a substantial re-rating of a stock trading near 7x trailing earnings. The supporting case rests on record margins, strong free cash flow, and ongoing deleveraging; the opposing case rests on elevated debt, soft end-market demand, and a growth profile below the sector average. With so few analysts covering the name and the target tied to 2027 earnings, the figure should be treated as a long-dated, high-uncertainty objective rather than a near-term expectation. Monitoring margins, cash flow, and debt reduction over the coming quarters will be essential to judging whether such a move is achievable.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MATV has been loosely correlated with OLN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MATV jumps, then OLN could also see price increases.
| Ticker / NAME | Correlation To MATV | 1D Price Change % | ||
|---|---|---|---|---|
| MATV | 100% | +1.82% | ||
| OLN - MATV | 51% Loosely correlated | -1.45% | ||
| AVNT - MATV | 51% Loosely correlated | +0.84% | ||
| HUN - MATV | 50% Loosely correlated | -1.32% | ||
| ASIX - MATV | 49% Loosely correlated | -2.59% | ||
| KRO - MATV | 48% Loosely correlated | -0.93% | ||
More | ||||